Singh, Jaipal
Lee, Young
Kellum, John A.
Funding for this research was provided by:
Indiana Clinical and Translational Sciences Institute (UL1TR001108)
National Institutes of Health, National Center for Advancing Translational Sciences and the National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health (R43DK125142)
Article History
Received: 5 May 2022
Accepted: 23 June 2022
First Online: 12 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: Jaipal Singh is a CSO at Vasculonics. John Kellum is a CMO at Spectral and Advisor at Vasculonics. Young Lee has no competing interests.